US Patent Issued to DROPLET BIOSCIENCES on Sept. 16 for "Methods for evaluating candidate therapy efficacy based on changes in lymphatic fluid biomarkers" (Missouri, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,416,626, issued on Sept. 16, was assigned to DROPLET BIOSCIENCES INC. (Melrose, Mass.).

"Methods for evaluating candidate therapy efficacy based on changes in lymphatic fluid biomarkers" was invented by Jose P. Zevallos (St. Louis), Aadel Chaudhuri (Chesterfield, Mo.) and Theresa Tribble (Melrose, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for using waste effluent biofluids in cell culture assays as all or part of the cell culture microenvironment. Methods of the invention contemplate that biofluids typically regarded as waste may be used in cell-based assays to achieve a cell culture microenvironment th...